Zobrazeno 1 - 6
of 6
pro vyhledávání: ''
Autor:
Seong Hyun, Jeong, Seok Jin, Kim, Dok Hyun, Yoon, Yong, Park, Hye Jin, Kang, Youngil, Koh, Gyeong-Won, Lee, Won-Sik, Lee, Deok-Hwan, Yang, Young Rok, Do, Min Kyoung, Kim, Kwai Han, Yoo, Yoon Seok, Choi, Hwan Jung, Yun, Jun Ho, Yi, Jae-Cheol, Jo, Hyeon-Seok, Eom, Jae-Yong, Kwak, Ho-Jin, Shin, Byeong Bae, Park, Shin Young, Hyun, Seong Yoon, Yi, Ji-Hyun, Kwon, Sung Yong, Oh, Hyo Jung, Kim, Byeong Seok, Sohn, Jong Ho, Won, Se-Hyung, Kim, Ho-Sup, Lee, Cheolwon, Suh, Won Seog, Kim
Publikováno v:
Cancer Research and Treatment. 54:1268-1277
PurposeFebrile neutropenia (FN) can cause suboptimal treatment and treatment-related mortality (TRM) in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). Mate
Autor:
Silvia Darb-Esfahani, Gunter von Minckwitz, Sanxing Guo, Carsten Denkert, Sibylle Loibl, B. Lederer
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
PurposePIK3CA, encoding for subunit p110a of phosphatidylinositol 3 kinase, is frequently mutated in breast cancer. PIK3CAmutation was predictive for pathological complete response (pCR) in human epidermal growth factor 2 positive breast cancer. This
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Determine the frequency and prognostic value of circulating Epstein-Barr virus (EBV) DNA copy number in angioimmunoblastic T-cell lymphoma (AITL) patients who were treated with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamid
Autor:
Young Up Cho, Seho Park, Gun Min Kim, Ji Heung Kim, Seung Il Kim, Ji Ye Kim, Hyung Seok Park, Joo Hoon Kim, Joohyuk Sohn
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Dose-dense chemotherapy (DD-CT) is a preferred (neo)adjuvant regimen in early breast cancer (BC). Although the results of reported randomized trials are conflicting, a recent metaanalysis showed improved overall and disease-free survival with
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin's lymphoma arising from a B-cell lineage characterized by the formation of malignant effusion in body cavities without evidence of a detectable tumor. The effusion contains tumor cells uni
Autor:
Bhumsuk Keam, Yoon Kyung Jeon, Dong Wan Kim, Hyerim Ha, Tae Min Kim, Se-Hoon Lee, Dae Seog Heo, Chul Woo Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The dose intensity of doxorubicin (DID) is important to the survival of diffuse large B cell lymphoma (DLBCL) patients. However, due to expected toxicities, most elderly patients cannot receive full doses of anthracyclines. The purpose of thi